Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K, likely with financial updates.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on September 6, 2024, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial transactions within the provided text.

Why It Matters

This filing indicates that Omega Healthcare Investors has made a regulatory submission, which may contain important updates for investors regarding the company's operations or financial status.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not inherently present new risks.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant
• September 6, 2024 (date) — Date of earliest event reported
• Maryland (location) — State of incorporation
• 303 International Circle Suite 200 Hunt Valley, Maryland 21030 (address) — Principal executive offices
• 410-427-1700 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001104659-24-097800.txt : 20240906 0001104659-24-097800.hdr.sgml : 20240906 20240906172125 ACCESSION NUMBER: 0001104659-24-097800 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240906 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 241285280 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2423444d1_8k.htm FORM 8-K false 0000888491 0000888491 2024-09-06 2024-09-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): September 6, 2024   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 8.01 Other Events.   On September 6, 2024, Omega Healthcare Investors, Inc. (the “ Company ”) entered into an “at-the-market” equity offering sales agreement (the “ Sales Agreement ”) with each of the institutions named therein (or certain of their respective affiliates) in their capacity as Sales Agents, as Forward Sellers and/or as Forward Purchasers, in each case as described below, relating to (i) the issuance and sale by the Company to or through the Sales Agents, from time to time, of shares (the “ Issuance Shares ”) of the Company’s common stock, par value $0.10 per share (“ Common Stock ”), and (ii)